| A study of agreement between the Naranjo algorithm and WHO-UMC criteria for causality assessment of adverse drug reactions MN Belhekar, SR Taur, RP Munshi Indian journal of pharmacology 46 (1), 117-120, 2014 | 159 | 2014 |
| Proteomic Investigation of Falciparum and Vivax Malaria for Identification of Surrogate Protein Markers S Ray, D Renu, R Srivastava, K Gollapalli, S Taur, T Jhaveri, S Dhali, ... Public Library of Science 7 (8), e41751, 2012 | 69 | 2012 |
| Serum proteome analysis of vivax malaria: An insight into the disease pathogenesis and host immune response S Ray, KS Kamath, R Srivastava, D Raghu, K Gollapalli, R Jain, SV Gupta, ... Journal of proteomics 75 (10), 3063-3080, 2012 | 58 | 2012 |
| Serum profiling of leptospirosis patients to investigate proteomic alterations R Srivastava, S Ray, V Vaibhav, K Gollapalli, T Jhaveri, S Taur, S Dhali, ... Journal of proteomics 76, 56-68, 2012 | 41 | 2012 |
| Association of polymorphisms of CYP2C9, CYP2C19, and ABCB1, and activity of P-glycoprotein with response to anti-epileptic drugs. SR Taur, NB Kulkarni, PP Gandhe, BK Thelma, SH Ravat, NJ Gogtay, ... Journal of Postgraduate Medicine 60 (3), 2014 | 33 | 2014 |
| Association of CYP2C9 polymorphisms with phenytoin toxicity in Indian patients AN Thakkar, SR Bendkhale, SR Taur, NJ Gogtay, UM Thatte Neurology India 60 (6), 577-580, 2012 | 32 | 2012 |
| Use of computerized tests to evaluate psychomotor performance in children with specific learning disabilities in comparison to normal children S Taur, S Karande, AA Saxena, NJ Gogtay, UM Thatte Indian Journal of Medical Research 140 (5), 644-648, 2014 | 26 | 2014 |
| Survey of ethics committee protocol approval letters: Compliance with Schedule Y/ICMR guidelines 2006 SR Taur, SB Bavdekar, UM Thatte A study of warning letters issued to clinical investigators and …, 2011 | 19 | 2011 |
| An audit of therapeutic drug monitoring services of anticonvulsants at a tertiary care hospital in India SR Taur, NB Kulkarni, NJ Gogtay, UM Thatte Therapeutic drug monitoring 35 (2), 183-187, 2013 | 16 | 2013 |
| Observational designs for real-world evidence studies SR Taur Perspectives in Clinical Research 13 (1), 12-16, 2022 | 14 | 2022 |
| Establishing institutional ethics committees: challenges and solutions–a review of the literature SK mUKTA, SR Taur, U m THATTE Indian Journal of Medical Ethics 11 (3), 2014 | 14 | 2014 |
| Survey of ethics committee protocol approval letters: Compliance with Schedule Y SR Taur, SB Bavdekar, UM Thatte ICMR guidelines, 214-6, 2006 | 10 | 2006 |
| A Multicenter evaluation of overall susceptibility and Antimicrobial Resistance among Streptococcus pneumoniae isolates N Kulkarni, A Routray, S Taur Cureus 15 (7), 2023 | 3 | 2023 |
| ‘Oxidative stress’-A new target in the management of diabetes mellitus AK Das, S Kalra, H Punyani, S Deshmukh, S Taur Journal of Family Medicine and Primary Care 12 (11), 2552-2557, 2023 | 2 | 2023 |
| Anticoagulation for stroke prevention of concomitant atrial fibrillation and end-stage renal disease: insights of cardiologists and nephrologists from India ES Swetha, S Taur, N Kulkarni Cureus 14 (12), 2022 | 1 | 2022 |
| Cost-effectiveness of apixaban versus other oral anticoagulants and aspirin for stroke prevention in atrial fibrillation in indian subcontinent N Kulkarni, S Taur, E Tichy, T Kongnakorn, R Sharma European Heart Journal 43 (Supplement_1), ehab849. 022, 2022 | 1 | 2022 |
| The Year Ahead: An initiative to assess the impact of an intervention “Speaking Book” on awareness among the potential participants about clinical trials in India U Thatte, S Taur Perspectives in Clinical Research 2 (3), 83, 2011 | 1 | 2011 |
| EE440 Cost-Effectiveness of 13-Valent Pneumococcal Conjugate Vaccine in Indian Adults Aged≥ 60 Years N Kulkarni, A Averin, S Taur, L Huang, D Hariharan, M Atwood, N Gupta Value in Health 26 (12), S136, 2023 | | 2023 |
| A Cardiologists’ Survey on the Use of Anticoagulants and Antiplatelets in Patients With Atrial Fibrillation and Acute Coronary Syndrome or Those Undergoing Percutaneous … N Kulkarni, S Taur, J Kaur, R Akolekar, ES Swetha Cureus 15 (2), 2023 | | 2023 |
| Safety of apixaban in Indian patients undergoing elective total knee replacement or total hip replacement surgery: A multi-center, phase-IV study H Panchal, A Agashe, PK Sancheti, NB Kulkarni, SR Taur SAGE Open Medicine 9, 20503121211049962, 2021 | | 2021 |
